JNJ-95566692
/ J&J
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
January 27, 2026
A Study of JNJ-95566692 in Participants With Non-Hodgkin Lymphoid Malignancies
(clinicaltrials.gov)
- P1 | N=130 | Recruiting | Sponsor: Janssen Research & Development, LLC | N=80 ➔ 130 | Not yet recruiting ➔ Recruiting
Enrollment change • Enrollment open • First-in-human • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology
December 30, 2025
A Study of JNJ-95566692 in Participants With Non-Hodgkin Lymphoid Malignancies
(clinicaltrials.gov)
- P1 | N=80 | Not yet recruiting | Sponsor: Janssen Research & Development, LLC
First-in-human • New P1 trial • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology
1 to 2
Of
2
Go to page
1